Encephalitis

Previous issues

Page Path

HOME
BROWSE ARTICLES
Previous issue

Volume 3(2); Apr 2023

Review Articles

Management of convulsive status epilepticus: recent updates: Jung-Ick Byun; encephalitis. 2023;3(2):39-43. Published online January 6, 2023; DOI: https://doi.org/10.47936/encephalitis.2022.00087
Cited By 2; Full text PubReader ePub PDF

Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases: Jung-Won Shin; encephalitis. 2023;3(2):44-53. Published online February 8, 2023; DOI: https://doi.org/10.47936/encephalitis.2022.00094
Cited By 1; Full text PubReader ePub PDF

Protein biomarkers in multiple sclerosis: Jun-Soon Kim; encephalitis. 2023;3(2):54-63. Published online April 4, 2023; DOI: https://doi.org/10.47936/encephalitis.2022.00101
Cited By 2; Full text PubReader ePub PDF

Original Article

The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review: Mark Erving H. Ramos, Steven G. Villaraza; encephalitis. 2023;3(2):64-70. Published online March 27, 2023; DOI: https://doi.org/10.47936/encephalitis.2022.00115; Full text PubReader ePub PDF

Case Report

Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews: Yoonkyung Lee, Seon-Jae Ahn, Han-Sang Lee et al.; encephalitis. 2023;3(2):71-77. Published online March 28, 2023; DOI: https://doi.org/10.47936/encephalitis.2022.00129; Full text PubReader ePub PDF

Volume 3, No. 2

MOST VIEWED MOST CITED

5,112	Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
5,639	Posttransplant lymphoproliferative disorder in a kidney transplant recipient: a case of Epstein-Barr virus-positive primary central nervous system lymphoma
3,770	Management of convulsive status epilepticus: recent updates
4,255	Lumbar puncture: considerations, procedure, and complications
7,118	Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy

Cited By 2	Chronic social stress during early development elicits unique behavioral changes in adulthood
Cited By 2	Management of convulsive status epilepticus: recent updates
Cited By 2	Protein biomarkers in multiple sclerosis
Cited By 1	Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report
Cited By 1	Clinical significance of Epstein-Barr virus polymerase chain reaction in cerebrospinal fluid

Editorial Office: 101, Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
Tel: +82-2-2072-0629 Fax: +82-2-765-7920 E-mail: editor@encephalitisjournal.org

Copyright © 2024 by Korean Encephalitis and Neuroinflammation Society.

prev

next